Comparative proteome approach demonstrates that platelet-derived growth factor C and D efficiently induce proliferation while maintaining multipotency of hMSCs

This is the first study that comprehensively describes the effects of the platelet-derived growth factor (PDGF) isoforms C and D during in vitro expansion of human mesenchymal stem cells (hMSCs). Our results show that PDGFs can enhance proliferation of hMSCs without affecting their multipotency. It...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental cell research 2013-10, Vol.319 (17), p.2649-2662
Hauptverfasser: Sotoca, Ana M., Roelofs-Hendriks, Jose, Boeren, Sjef, van der Kraan, Peter M., Vervoort, Jacques, van Zoelen, Everardus J.J., Piek, Ester
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This is the first study that comprehensively describes the effects of the platelet-derived growth factor (PDGF) isoforms C and D during in vitro expansion of human mesenchymal stem cells (hMSCs). Our results show that PDGFs can enhance proliferation of hMSCs without affecting their multipotency. It is of great value to culture and expand hMSCs in a safe and effective manner without losing their multipotency for manipulation and further development of cell-based therapies. Moreover, differential effects of PDGF isoforms have been observed on lineage-specific differentiation induced by BMP2 and Vitamin D3. Based on label-free LC-based quantitative proteomics approach we have furthermore identified specific pathways induced by PDGFs during the proliferation process, showing the importance of bioinformatics tools to study cell function. •PDGFs (C and D) significantly increased the number of multipotent undifferentiated hMSCs.•Enhanced proliferation did not impair the ability to undergo lineage-specific differentiation.•Proteomic analysis confirmed the overall signatures of the ‘intact’ cells.
ISSN:0014-4827
1090-2422
DOI:10.1016/j.yexcr.2013.07.027